T1ρ mapping for assessment of renal allograft fibrosis
- PMID: 30666744
- DOI: 10.1002/jmri.26656
T1ρ mapping for assessment of renal allograft fibrosis
Abstract
Background: There is an unmet need for noninvasive methods to diagnose and stage renal allograft fibrosis.
Purpose: To investigate the utility of T1ρ measured with MRI for the assessment of fibrosis in renal allografts.
Study type: Institutional Review Board (IRB)-approved prospective.
Subjects: Fifteen patients with stable functional allograft (M/F 9/6, mean age 56 years) and 12 patients with allograft dysfunction and established fibrosis (M/F 6/6, mean age 51 years).
Field strength/sequence: T1ρ imaging at 1.5T using a custom-developed sequence.
Assessment: Average T1ρ in the cortex and medulla was quantified and T1ρ repeatability (expressed by the coefficient of variation [CV]) was measured in four patients.
Statistical tests: Differences in T1ρ values between the 2 groups were assessed using Mann-Whitney U-tests. Diagnostic performance of T1ρ for differentiation between functional and fibrotic allografts was evaluated using receiver operating characteristic (ROC) analysis. Spearman correlations of T1ρ with Masson's trichrome-stained fractions and serum estimated glomerular filtration rate (eGFR) were assessed.
Results: Higher T1ρ repeatability was found for cortex compared with medulla (mean CV T1ρ cortex 7.4%, medulla 13.3%). T1ρ values were significantly higher in the cortex of fibrotic vs. functional allografts (111.8 ± 17.2 msec vs. 99.0 ± 11.0 msec, P = 0.027), while there was no difference in medullary T1ρ values (122.6 ± 20.8 msec vs. 124.3 ± 20.8 msec, P = 0.789). Cortical T1ρ significantly correlated with Masson's trichrome-stained fractions (r = 0.515, P = 0.044) and eGFR (r = -0.546, P = 0.004), and demonstrated an area under the curve (AUC) of 0.77 for differentiating between functional and fibrotic allografts (sensitivity and specificity of 75.0% and 86.7%, using threshold of 106.9 msec).
Data conclusion: Our preliminary results suggest that T1ρ is a potential imaging biomarker of renal allograft fibrosis. These results should be verified in a larger study.
Level of evidence: 1 Technical Efficacy: Stage 1 J. Magn. Reson. Imaging 2019;50:1085-1091.
Keywords: T1rho; fibrosis; renal allograft.
© 2019 International Society for Magnetic Resonance in Medicine.
References
-
- Liu YH. Renal fibrosis: New insights into the pathogenesis and therapeutics. Kidney Int 2006;69:213-217.
-
- Khan H, Mubarak M, Aziz T, et al. Prevalence and risk factors for early chronic allograft nephropathy in a live related renal transplant program. J Nephropathol 2014;3:69-79.
-
- Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR. The natural history of chronic allograft nephropathy. N Engl J Med 2003;349:2326-2333.
-
- Furness PN, Philpott CM, Chorbadjian MT, et al. Protocol biopsy of the stable renal transplant: A multicenter study of methods and complication rates. Transplantation 2003;76:969-973.
-
- Korbet SM, Volpini KC, Whittier WL. Percutaneous renal biopsy of native kidneys: A single-center experience of 1,055 biopsies. Am J Nephrol 2014;39:153-162.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
